Tom Verbelen

KU Leuven

Papers

2

Total Citations

6

H-Index

2

About

Tom Verbelen is a pioneering cardiothoracic surgeon whose research focuses on advancing minimally invasive coronary revascularization techniques. His major contributions center on robot-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB), particularly using bilateral internal thoracic arteries for total arterial grafting. In a landmark 2024 propensity score–matched study, Verbelen demonstrated that RA-MIDCAB offers outcomes comparable to off-pump coronary artery bypass (OPCAB), with the added benefits of reduced surgical trauma and faster recovery—a finding that has already garnered 4 citations and is reshaping surgical decision-making. His earlier case reports on hybrid myocardial revascularization and multivessel MIDCAB (2019, 2 citations) expanded the indications for robotic surgery, showing that even complex multivessel disease can be treated without sternotomy. Verbelen’s work bridges the gap between traditional open-heart surgery and cutting-edge robotic techniques, making him a key figure in the movement toward less invasive cardiac care. His research not only validates the safety and efficacy of RA-MIDCAB but also provides a roadmap for integrating total arterial grafting into minimally invasive workflows, directly benefiting patients with faster recoveries and fewer complications.

Research Focus

Key Achievements

2
H-Index
2
Papers
6
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted MIDCAB Using Bilateral Internal Thoracic Artery: A Propensity Score–Matched Study With OPCAB Patients
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: KU Leuven

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago